tiprankstipranks
Eurobio-Scientific SA (FR:ALERS)
:ALERS
France Market
ALERS
Eurobio-Scientific SA
RESEARCH TOOLSreports
Want to see FR:ALERS full AI Analyst Report?

Eurobio-Scientific SA (ALERS) Ratios

1 Followers

Eurobio-Scientific SA Ratios

FR:ALERS's free cash flow for Q4 2025 was €0.43. For the 2025 fiscal year, FR:ALERS's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.98 1.98 2.03 2.72 2.59
Quick Ratio
 1.36 1.36 1.42 2.32 2.21
Cash Ratio
 0.44 0.44 0.49 0.93 0.83
Solvency Ratio
 0.15 0.19 0.16 0.13 0.22
Operating Cash Flow Ratio
 0.28 0.41 0.38 0.51 0.73
Short-Term Operating Cash Flow Coverage
 5.71 8.40 23.04 2.02 3.05
Net Current Asset Value
€ 18.75M€ 18.75M€ 11.27M€ 2.75M€ -9.38M
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.06 0.13 0.32 0.34
Debt-to-Equity Ratio
 0.09 0.09 0.19 0.57 0.66
Debt-to-Capital Ratio
 0.08 0.08 0.16 0.36 0.40
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.13 0.32 0.35
Financial Leverage Ratio
 1.40 1.40 1.44 1.81 1.92
Debt Service Coverage Ratio
 3.86 3.27 2.86 1.27 2.38
Interest Coverage Ratio
 6.36 3.72 2.39 2.29 23.97
Debt to Market Cap
 0.05 0.04 0.11 0.52 0.52
Interest Debt Per Share
 1.74 1.85 3.87 9.42 11.24
Net Debt to EBITDA
 -0.22 -0.22 0.60 2.09 1.63
Profitability Margins
Gross Profit Margin
44.71%40.47%46.44%44.00%42.62%
EBIT Margin
7.92%6.39%7.74%8.68%20.29%
EBITDA Margin
11.64%11.66%13.17%18.79%26.53%
Operating Profit Margin
7.92%6.39%8.65%7.76%20.23%
Pretax Profit Margin
4.63%4.62%4.07%5.34%19.45%
Net Profit Margin
2.93%2.90%2.58%3.70%16.34%
Continuous Operations Profit Margin
2.93%2.90%2.58%3.70%16.34%
Net Income Per EBT
63.25%62.82%63.49%69.30%84.01%
EBT Per EBIT
58.42%72.22%47.01%68.80%96.16%
Return on Assets (ROA)
1.92%1.91%1.56%1.53%7.55%
Return on Equity (ROE)
2.71%2.66%2.24%2.76%14.47%
Return on Capital Employed (ROCE)
6.35%5.13%6.29%3.85%11.30%
Return on Invested Capital (ROIC)
3.93%3.16%3.94%2.52%8.99%
Return on Tangible Assets
4.69%4.65%3.86%2.96%41.82%
Earnings Yield
2.19%1.96%1.55%2.64%11.98%
Efficiency Ratios
Receivables Turnover
 4.46 4.47 4.67 4.14 3.81
Payables Turnover
 4.47 4.82 5.42 5.62 4.73
Inventory Turnover
 3.26 3.51 3.08 3.41 4.04
Fixed Asset Turnover
 13.36 13.38 12.14 10.62 12.05
Asset Turnover
 0.66 0.66 0.60 0.41 0.46
Working Capital Turnover Ratio
 3.18 3.72 2.27 1.43 1.34
Cash Conversion Cycle
 112.20 109.84 129.10 130.25 108.89
Days of Sales Outstanding
 81.83 81.69 78.11 88.15 95.88
Days of Inventory Outstanding
 112.05 103.88 118.38 107.01 90.26
Days of Payables Outstanding
 81.68 75.73 67.38 64.91 77.25
Operating Cycle
 193.88 185.57 196.48 195.16 186.14
Cash Flow Ratios
Operating Cash Flow Per Share
 1.23 1.84 1.63 2.40 4.09
Free Cash Flow Per Share
 0.17 0.61 1.31 2.04 3.82
CapEx Per Share
 1.06 1.23 0.32 0.36 0.28
Free Cash Flow to Operating Cash Flow
 0.14 0.33 0.81 0.85 0.93
Dividend Paid and CapEx Coverage Ratio
 1.16 1.50 5.13 6.60 14.77
Capital Expenditure Coverage Ratio
 1.16 1.50 5.13 6.60 14.77
Operating Cash Flow Coverage Ratio
 0.80 1.18 0.49 0.27 0.37
Operating Cash Flow to Sales Ratio
 0.08 0.11 0.11 0.20 0.27
Free Cash Flow Yield
0.81%2.52%5.20%12.39%18.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 45.60 50.93 64.69 37.92 8.35
Price-to-Sales (P/S) Ratio
 1.29 1.48 1.67 1.40 1.36
Price-to-Book (P/B) Ratio
 1.22 1.36 1.45 1.05 1.21
Price-to-Free Cash Flow (P/FCF) Ratio
 124.06 39.72 19.24 8.07 5.34
Price-to-Operating Cash Flow Ratio
 17.55 13.24 15.49 6.85 4.97
Price-to-Earnings Growth (PEG) Ratio
 2.61 2.21 -6.95 -0.47 -0.14
Price-to-Fair Value
 1.22 1.36 1.45 1.05 1.21
Enterprise Value Multiple
 10.86 12.45 13.29 9.56 6.77
Enterprise Value
 213.18M 245.26M 271.06M 234.72M 274.28M
EV to EBITDA
 10.86 12.45 13.29 9.56 6.77
EV to Sales
 1.26 1.45 1.75 1.80 1.80
EV to Free Cash Flow
 121.61 39.04 20.16 10.33 7.03
EV to Operating Cash Flow
 16.62 13.01 16.23 8.77 6.55
Tangible Book Value Per Share
 3.11 3.16 2.47 1.98 -9.60
Shareholders’ Equity Per Share
 17.65 17.95 17.45 15.71 16.86
Tax and Other Ratios
Effective Tax Rate
 0.37 0.37 0.37 0.31 0.16
Revenue Per Share
 16.19 16.49 15.12 11.71 14.93
Net Income Per Share
 0.47 0.48 0.39 0.43 2.44
Tax Burden
 0.63 0.63 0.63 0.69 0.84
Interest Burden
 0.58 0.72 0.53 0.62 0.96
Research & Development to Revenue
 0.03 0.03 0.03 0.07 0.02
SG&A to Revenue
 0.31 0.31 0.29 0.11 0.07
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.62 3.88 4.18 5.54 1.68
Currency in EUR